Effects of pigment epithelium-derived factor on lipid metabolism in HepG2 hepatocytes
返回论文页
|更新时间:2023-12-18
|
Effects of pigment epithelium-derived factor on lipid metabolism in HepG2 hepatocytes
Journal of Chongqing Medical UniversityVol. 37, Issue 6, Pages: 477-480(2012)
作者机构:
1. 重庆医科大学附属第一医院1. 体检中心
2. 内分泌科,重庆,400016
作者简介:
基金信息:
DOI:
CLC:
Published:2012,
扫 描 看 全 文
ZHONG Li, LUO Mei, XIA Wei, et al. Effects of pigment epithelium-derived factor on lipid metabolism in HepG2 hepatocytes. [J]. Journal of Chongqing Medical University 37(6):477-480(2012)
DOI:
ZHONG Li, LUO Mei, XIA Wei, et al. Effects of pigment epithelium-derived factor on lipid metabolism in HepG2 hepatocytes. [J]. Journal of Chongqing Medical University 37(6):477-480(2012)DOI:
Effects of pigment epithelium-derived factor on lipid metabolism in HepG2 hepatocytes
PEDF)对人HepG2肝细胞脂代谢的影响。方法:分别用重组人PEDF细胞因子和PEDF抗体干预HepG2肝细胞,采用实时荧光定量PCR和Western blot方法检测脂质合成和分解的关键酶mRNA及蛋白水平的变化;裂解细胞后用酶法测定细胞内甘油三酯(Triglyceride,TG)含量。结果:(1)PEDF干预人HepG2肝细胞后,固醇调节元件结合蛋白1(Sterol regulatory element-binding protein1,SREBP1)、脂肪酸合成酶(Fatty acid syn-thase,FAS)、乙酰辅酶A羧化酶1(Acetyl coenzyme A carboxylase1,ACC1)、羟甲基戊二酰辅酶还原酶(HMG-coA reductases,HMGR)mRNA的表达较正常对照分别降低39%、38%、61%、32%(P<0.05),而脂肪甘油三酯脂酶(Adipose triglyceride lipase,ATGL)的表达增加了98%(P<0.05);用PEDF抗体干预后,SREBP1、FAS、ACC1、HMGR mRNA的表达分别较正常对照增加92%、56%、67%、42%(P<0.05),ATGL的表达则减少了51%(P<0.05)。(2)在蛋白水平,PEDF干预后 FAS、ACC1、HMGR表达较正常组分别减少58%、54%、43%,而 ATGL的表达增加20%(P<0.05);用 PEDF抗体干预后,FAS、ACC1、HMGR表达较正常组分别增加41%、39%、48%,而ATGL的表达减少40%(P<0.05)。(3)PEDF的干预使细胞内TG明显减少[(410.40±13.43) mg/g vs. (234.70±35.70) mg/g,P<0.05],而 PEDF抗体干预后,细胞内TG含量有上升趋势,但无统计学差异[(410.40±13.43) mg/g vs. (440.32±25.67) mg/g,P=0.67]。结论:PEDF在 HepG2肝细胞中可抑制脂肪酸的合成,并促进脂肪分解,从而降低细胞内TG的含量。
Abstract
【Abstract】Objective:To investigate the effects of pigment epithelium-derived factor(PEDF) on lipid metabolism in HepG2 hepato-cytes. Methods:HepG2 hepatocytes were treated with recombinant human PEDF or PEDF antibody. The key enzymes of lipid metabolism were detected by real time quantitative PCR and Western blot;intracellular triglyceride(TG) content was determined by enzymatic method. Results:(1)PEDF decreased the mRNA levels of sterol regulatory element-binding protein1(SREBP1),fatty acid synthase(FAS),acetyl coenzyme A carboxylase1(ACC1) and HMG-coA reductases(HMGR) by 39%,38%,61%,32% respectively(P<0.05),while increased the mRNA level of adipose triglyceride lipase(ATGL) by 98%(P<0.05). On the contrary,PEDF an-tibody increased the mRNA levels of SREBP1,FAS,ACC1,HMGR by 92%,56%,67%,42% respectively(P<0.05),and decreased the mRNA level of ATGL by 51%(P<0.05). (2)Besides,PEDF decreased the protein levels of FAS,ACC1,HMGR by 58%,54%,43% respectively(P<0.05),and increased the protein level of ATGL by 20%(P<0.05). While PEDF antibody increased the protein levels of FAS,ACC1,HMGR expression by 41%,39%,48% respectively(P<0.05),and decreased the protein level of ATGL by 40%(P<0.05). (3)PEDF significantly reduced intracellular TG content[(410.40±13.43) mg/g vs. (234.70±35.70) mg/g,P<0.05],but PEDF antibody treated group showed an increase tendency of TG content,however without significant difference[(410.40±13.43) mg/g vs. (440.32±25.67) mg/g,P=0.67]. Conclusion:In HepG2 hepatocytes,PEDF reduced the intracellular TG content by inhibiting fatty acid synthesis,and promoting lipolysis.
Research progress of circular RNA in cancer metabolism
Relationship between plasma vascular endothelial growth factor B and the first-phase of glucose-stimulated insulin secretion from pancreatic β cell in patients with type 2 diabetes mellitus
Effect of oxymatrine on lipid accumulation in Hepg2 cells exposed to palmitic acid
Changes of the lipid metabolism in impaired glucose tolerance individuals
Study on the relationship between hyperuricemia and lipid metabolism, hypertention abnormality,and baric index by 9528 examples of their health examination in chongqing
Related Author
Yu Chengpeng
Song Jia
Huang Wenjie
Wu Jing
He Qin
Qu Hua
Wang Hang
Luo Yuanyuan
Related Institution
Hepatic Surgery Center,Tongji Hospital,Huazhong University of Science and Technology
Department of Endocrinology,The First Affiliated Hospital of Chongqing Medical University
Graduate Institute of Hebei Medical University
Geriatric Laboratory of Hebei Province
Department of Endocrinology,General Hospital of Hebei